Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging.

Details

Language :

English

ISSN :

22745807

Volume :

8

Issue :

4

Database :

Complementary Index

Journal :

Journal of Prevention of Alzheimer's Disease

Publication Type :

Academic Journal

Accession number :

152627097

Full Text :

https://doi.org/10.14283/jpad.2021.56